Abstract
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have